Suman Sen

Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors

Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski et al. · Journal of Clinical Oncology · 2014 · 205 citations · Full text

CD22 Ligand Binding Regulates Normal and Malignant B Lymphocyte Survival In Vivo

Karen M. Haas, Suman Sen, Isaac G. Sanford et al. · The Journal of Immunology · 2006 · 71 citations

Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects

Shyeilla V. Dhuria, Heidi J. Einolf, James B. Mangold et al. · The Journal of Clinical Pharmacology · 2013 · 23 citations

Healthy Subjects, Midazolam Cmax, Apoptosis +20

Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials

Rong Liu, Ying Yuan, Suman Sen et al. · Statistics in Biopharmaceutical Research · 2022 · 11 citations · Full text

Pharmacotherapy, Metronomic Chemotherapy, Mtd Identification +19